Efficacy Study of Dysport® in the Treatment of Anal Fissure.
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
To evaluate the effect on healing rates of two different prognostic factors in patients
treated with Dysport® for anal fissure: duration of fissure and dose of study drug
Phase:
Phase 2
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA